Hype or Hope? CIMAvax A Cuban Lung Cancer Vaccine
September 19, 2017
Hosted by Cancer Support Community
[Download MP3] [itunes] [Bookmark Episode]
Episode Description
In the latest installment of our special series “Innovation Happens,” we take a look at CIMAvax, a promising lung cancer vaccine developed in Cuba that is getting a lot of attention here in the United States. It is being studied in an FDA approved clinical trial at Roswell Park Cancer Institute-- the first Cuban therapy to be tested in the US. Our guest is Dr. Mary Reid, the Director of Cancer Screening and Survivorship at Roswell Park and a key member of the team that is collaborating with Cuban scientists on CIMAvax. Dr. Reid shares with us the history of the vaccine and how it could spur a new age of American-Cuban medical collaboration.
Frankly Speaking About Cancer with the Cancer Support Community
Tuesdays at 1 PM Pacific Time on VoiceAmerica Health and Wellness Channel
Frankly Speaking about Cancer is a program that inspires, educates, and empowers patients, survivors, and caregivers living with cancer. Hosted by the Cancer Support Community, this award-winning show features health professionals, elected leaders, advocates, and celebrities who share their insights and experiences. Timely and relevant, each episode helps us live well with cancer. Join the Cancer Support Community Tuesday afternoons at 1 P.M. PT and 4 P.M. ET on the Voice America Health and Wellness network.
Show Links
